Date
- Monday, 17 November 2014, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
The European Union China Working Group on Pharmaceuticals, which brings together the European Medicines Agency (EMA), the European Commission (EC) and the China Food and Drugs Administration, meets on 18 November to progress discussions on active-pharmaceutical-ingredient, good-clinical-practice and good-pharmacovigilance-practice inspection-related topics. The ninth International Summit of Heads of Medicines Regulatory Agencies takes place on 19-21 November, with representatives from EMA, EC, and a number of European, national and international partner regulators, including the World Health Organization. Discussions include registration of generics, biosimilars, access to medicines, innovative products and major public health concerns such as Ebola, antimicrobial resistance and dementia. The International Coalition of Medicines Regulatory Authorities meets on 20 November to review cooperation in good-manufacturing-practice inspection, information-sharing and capacity-building.